Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T14:53:07.219Z.
Calculation as of: 2026-10-06T14:53:07.219Z.
Quote observation: 2026-10-06T14:49:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2ce25f957fe83095360266a8eba44a0c9f304ca71e6017df3a9cc6b1c586d311
PEG RATIO
N/A
Market Cap
$381.82M
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $385.63M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $384.11M | N/A | 1.74 | 1.65 | 1.65 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $379.97M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $381.82M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $371.03M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $403.52M | N/A | 116.35 | 116.35 | 57.53 |
| Carlsmed, Inc. (CARL)vs › | $404.78M | N/A | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $405.52M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $356.64M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.54M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute